News

Sherin and Lodgen sponsors Art in Giving and CureDuchenne Charity Casino Night

Sherin and Lodgen is sponsoring Art in Giving and CureDuchenne’s Charity Casino Night on October 20th in Kendall Square to help save the lives of those with Duchenne muscular dystrophy. A portion of the proceeds will go directly to Art in Giving, a nonprofit that funds pediatric cancer research.

Click here to learn more about the event.

Gary M. Markoff, partner in the firm’s corporate and real estate departments, is a member of Art in Giving’s board of advisors and serves as the organization’s legal counsel.

About CureDuchenne

CureDuchenne is a national nonprofit organization dedicated to finding a cure for Duchenne muscular dystrophy, the most common and lethal form of muscular dystrophy. Duchenne affects more than 300,000 people worldwide, most of them boys and young men. With the help of CureDuchenne’s distinguished international panel of Scientific Advisors, funds raised by CureDuchenne support the most promising research aimed at treating and curing Duchenne. To date, nine CureDuchenne funded research projects have advanced into human clinical trials. CureDuchenne also brings physical therapy and standard of care to local communities around the country through its CureDuchenne Cares Program.

About Art in Giving

Art in Giving is a nonprofit with a unique business model that generates funding for pediatric cancer research through the sale and loan of fine art. Art in Giving combines the ingenuity of childhood cancer researchers with the creativity of artists. Researchers stretch the limits of their minds in a relentless pursuit to cure cancer.  Artists stretch the limits of their imagination to appeal to our hearts and souls.  Art in Giving follows a unique path that combines the creativity and generosity of its artists with the needs of talented cancer researchers. Up to 50% of the proceeds from the sale of art through the efforts of Art in Giving are donated to The Rachel Molly Markoff Foundation. The Foundation is a 501(c)(3) public charity that makes grants to cancer researchers.